Munich - Delayed Quote EUR
TerrAscend Corp (TED.MU)
0.2860
+0.0520
+(22.22%)
At close: April 25 at 8:04:34 AM GMT+2
Loading Chart for TED.MU
- Previous Close
0.2340 - Open
0.2860 - Bid 0.2600 x --
- Ask 0.3220 x --
- Day's Range
0.2860 - 0.2860 - 52 Week Range
0.2240 - 1.6500 - Volume
0 - Avg. Volume
9 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: TED.MU
View MorePerformance Overview: TED.MU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
TED.MU
51.53%
S&P/TSX Composite index (^GSPTSE)
0.37%
1-Year Return
TED.MU
81.67%
S&P/TSX Composite index (^GSPTSE)
12.91%
3-Year Return
TED.MU
94.20%
S&P/TSX Composite index (^GSPTSE)
17.60%
5-Year Return
TED.MU
96.99%
S&P/TSX Composite index (^GSPTSE)
71.36%
Compare To: TED.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.6850
+8.73%
Mkt Cap EUR 246.407M
Industry Drug Manufacturers—Specialty & Generic
4.9200
+20.59%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.3200
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.7550
+19.84%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Mkt Cap undefined -
Industry -
5.28
+14.73%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.9200
0.00%
Mkt Cap EUR 340.492M
Industry Drug Manufacturers—Specialty & Generic
5.53
+8.01%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4404
+12.20%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: TED.MU
View MoreValuation Measures
As of 4/25/2025
Market Cap
88.59M
Enterprise Value
281.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.31
Price/Book (mrq)
0.54
Enterprise Value/Revenue
1.04
Enterprise Value/EBITDA
51.73
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--